CVTX - CV Therapeutics, Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CVTX - CV Therapeutics, Inc.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Todd N. Weisrock who started this subject	4/8/2003 8:26:12 PM
From: mopgcw	Read Replies (1) of 411

Wellington has a basis of over $30?? DJ CV Therapeutics Ends Pact With Acqua Wellington Fund>CVTX Dow Jones News Service ~ April 8, 2003 ~ 3:48 pm EST WASHINGTON (Dow Jones)--CV Therapeutics Inc. (CVTX) terminated a stock purchase agreement because the Acqua Wellington North American Equities Fund has nearly purchased the maximum amount of stock allowed, according to a regulatory filing Tuesday. Acqua Wellington has purchased a little over 3.6 million CV Therapeutics shares, generating net proceeds of $113.7 million for the company, the company said in a filing with the Securities and Exchange Commission. Nasdaq National Market rules limited the amount of stock CV Therapeutics could sell under the agreement to 3.7 million shares, the filing said. The stock-purchase agreement established in August 2000 allowed the fund to buy up to $149 million of CV Therapeutics stock at a discount to the market price. CV Therapeutics and Acqua Wellington mutually agreed to terminate the pact Monday, the filing said. Shares of CV Therapeutics, a Palo Alto, Calif., biopharmaceutical company, recently traded down 2.2%, or 39 cents, to $17.21.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next